# JJJ Medical LLC

> JJJ Medical is a medical device company developing the **Eagle Ray™ Graft Positioning Device**, the first universal arthroscopic deployment system for rotator cuff augmentation patches. FDA Class I exempt (product code 888.4540), patent-pending.

## Company

- **Legal name:** JJJ Medical LLC
- **Trade name:** JJJ Medical
- **Industry:** Medical Devices — Orthopedic Sports Medicine
- **Primary domain:** https://jjjmed.com
- **Contact:** info@JJJMed.com
- **Made in:** United States

## Product: Eagle Ray™ Graft Positioning Device

The Eagle Ray is the first patch-agnostic deployment device for arthroscopic rotator cuff augmentation. Existing patches (e.g., REGENETEN, FiberLocker, BioBrace, Tapestry, Integrity) work clinically — but deploying them through an arthroscopic portal is mechanically difficult. Surgeons currently fold, roll, or improvise. Eagle Ray standardizes the deployment with a three-step workflow:

1. **EXPOSE** — Retract the sheath to reveal the loaded patch under full arthroscopic visualization.
2. **EXPAND** — Activate the expansion mechanism to unfurl the patch at the repair site.
3. **EJECT** — Release the positioned patch with a single action; device cleanly disengages.

### Regulatory status

- FDA Class I exempt, product classification code **888.4540** — exempt from 510(k) pre-market notification
- Patent application pending — covers universal deployment mechanism, graft positioning system, and the Expose-Expand-Eject workflow
- Single-use, sterile, pre-packaged

### Compatibility

Eagle Ray works with any commercially available rotator cuff augmentation patch, including:
- ZuriMED FiberLocker
- Anika Integrity
- ConMed BioBrace
- Zimmer-Biomet Tapestry

## Founders

- **Justin T. Smith, MD** — Co-Founder & Chief Medical Officer. Board-certified orthopedic sports surgeon based in Charlotte, NC. Conceived the device after experiencing the deployment problem firsthand in the OR.
- **Jeremy Smith** — Co-Founder & CEO. Leads business strategy, regulatory affairs, and partnership development.
- **Jeff Broadrick** — Co-Founder & Chief Technology Officer (CTO). Biomedical engineer responsible for mechanical design, prototyping, and manufacturing.

## Key claims and citations

- **Re-tear rates remain high after rotator cuff repair**, especially for large/massive tears. Control-group retear rates in recent RCTs range from 34% to 65%. [Orozco et al., *Arthroscopy* 2024](https://pubmed.ncbi.nlm.nih.gov/37734446/)
- **Overall pooled retear rate** across all rotator cuff repair procedures is approximately 16% at long-term follow-up. [Longo et al., *BMC Musculoskelet Disord* 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8408924/)
- **Over 30 million tendon-related procedures** are performed worldwide each year. [Yang, Rothrauff, Tuan, *Birth Defects Res C Embryo Today* 2013](https://pubmed.ncbi.nlm.nih.gov/24078497/)
- **Patch augmentation significantly reduces retear rates** in rotator cuff repair (OR 0.32; 95% CI 0.18–0.55). [de Andrade et al., *Orthop J Sports Med* 2022](https://pmc.ncbi.nlm.nih.gov/articles/PMC8961381/)

## What JJJ Medical is looking for

- **Surgeon evaluators** — orthopedic sports/shoulder surgeons interested in trying the device
- **Strategic partners** — companies with augmentation patch portfolios seeking a universal deployment system (licensing, distribution, OEM integration, or platform acquisition)
- **Regulatory and clinical inquiries** — contact info@JJJMed.com

## Trademarks and disclaimers

Eagle Ray™ is a trademark of JJJ Medical LLC. All other product names referenced (REGENETEN, FiberLocker, BioBrace, Tapestry, Integrity, etc.) are trademarks of their respective owners and are referenced only for compatibility context. JJJ Medical is not affiliated with the manufacturers of any third-party augmentation patches.

The Eagle Ray™ Graft Positioning Device is intended for use by qualified healthcare professionals only. Information on this site does not constitute medical advice.